squamous cell carcinoma of pancreas
squamous cell carcinoma of pancreas
Explore linked clinical trials. Standard reference: MONDO:00185212 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation | pancreatic acinar cell carcinoma, pancreatic adenosquamous carcinoma, squamous cell carcinoma of pancreas | Recruiting | Phase 2 | 2026-10-08 | NCT04858334 | |
| The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pancreatic Carcinoma, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic acinar cell carcinoma, pancreatic adenocarcinoma, pancreatic adenosquamous carcinoma, pancreatic ductal adenocarcinoma, pancreatic neoplasm, squamous cell carcinoma of pancreas | Active, not recruiting | Phase 2 / Phase 3 | 2026-01-07 | NCT06115499 |